Precigen Operating Expenses 2011-2026 | PGEN

Annual Operating Expenses Precigen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
120 M	139 M	106 M	-	-	-	203 M	542 M	289 M	254 M	257 M	123 M	81.8 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
542 M	81.8 M	211 M

Quarterly Operating Expenses Precigen

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
29.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	71.7 M	73.4 M	82 M	-	98.9 M	95 M	92.3 M	-	90.8 M	89.7 M	85.1 M	-	77.8 M	75.7 M	84 M	-	61.3 M	62.3 M	121 M	-	36.2 M	29.9 M	25.7 M	-	18.1 M	20.9 M	17.9 M	-	19.4 M	24 M	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
121 M	17.9 M	61.8 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	15.3 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	6.79 M	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	78.4 M	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	70.6 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Esperion Therapeutics ESPR	343 M	$ 3.14	0.16 %	$ 653 M	USA
Eton Pharmaceuticals ETON	43.6 M	$ 34.42	4.65 %	$ 926 M	USA
Forte Biosciences FBRX	70.7 M	$ 20.35	1.4 %	$ 263 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	26.2 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Arcturus Therapeutics Holdings ARCT	158 M	$ 6.84	2.17 %	$ 187 M	Israel
Grifols, S.A. GRFS	1.64 B	$ 8.21	4.72 %	$ 5.58 B	Spain
Generation Bio Co. GBIO	162 M	-	-	$ 344 M	USA
IMV IMV	35.1 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
BioNTech SE BNTX	512 M	$ 90.48	3.06 %	$ 21.9 B	Germany
Autolus Therapeutics plc AUTL	145 M	$ 1.64	0.61 %	$ 436 M	Britain
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Heron Therapeutics HRTX	281 M	$ 0.85	0.57 %	$ 142 M	USA
Cyclacel Pharmaceuticals CYCCP	9.17 M	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	32.2 M	$ 2.74	0.18 %	$ 256 M	Israel
Anika Therapeutics ANIK	51.6 M	$ 15.15	2.23 %	$ 217 M	USA
Advaxis ADXS	19.6 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	10.4 M	$ 3.39	4.17 %	$ 5.58 M	Israel
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	231 M	$ 1.52	2.7 %	$ 178 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	305 M	$ 20.45	4.9 %	$ 2.6 B	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA